Ad
related to: mitochondrial disease autism treatment
Search results
Results From The WOW.Com Content Network
Robert K. Naviaux (born in 1956) is an American physician-scientist who specializes in mitochondrial medicine and complex chronic disorders. He discovered the cause of Alpers syndrome, [1] [2] and was part of the team that reported the first mitochondrial DNA (mtDNA) mutation to cause genetic forms of autism. [3]
This may be, in part, due to the unclear distinction between mitochondrial disease and dysfunction. Mitochondrial diseases are difficult to diagnose and have become better known and detected. Studies indicating the highest rates of mitochondrial diagnosis are usually the most recent. [7] Some drugs are toxic to mitochondria. These can trigger ...
Richard Eugene Frye is an American autism researcher and associate professor at Arizona Children's Hospital in Phoenix, and formerly of the University of Arkansas for Medical Sciences's department of pediatrics, [1] as well as the Director of the Autism Multispecialty Clinic at Arkansas Children’s Hospital. [2]
Dimethylglycine has been suggested for use as an athletic performance enhancer, immunostimulant, and a treatment for autism, epilepsy, or mitochondrial disease. [1] There is no evidence that dimethylglycine is effective for treating mitochondrial disease. [2]
Researchers have found that a novel drug molecule may fight the development of early-onset Parkinson’s disease in younger people. The new compound, BIO-2007817, is from the family of ...
Mitochondrial disease is a group of disorders caused by mitochondrial dysfunction. Mitochondria are the organelles that generate energy for the cell and are found in every cell of the human body except red blood cells .
Research on mitochondrial dysfunction in Crohn’s disease may have broader implications for understanding other inflammatory and autoimmune diseases, as mitochondrial dysfunction is increasingly ...
Treatment of dysautonomia can be difficult; since it is made up of many different symptoms, a combination of drug therapies is often required to manage individual symptomatic complaints. In the case of autoimmune neuropathy, treatment with immunomodulatory therapies is done. If diabetes mellitus is the cause, control of blood glucose is ...